MESO
Mesoblast Ltd
NASDAQ: MESO · HEALTHCARE · BIOTECHNOLOGY
$15.55
+2.17% today
Updated 2026-04-29
Market cap
$2.01B
P/E ratio
—
P/S ratio
30.75x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$10 – $22
Volume
0.3M
Mesoblast Ltd (MESO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+77.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+75.0%
Most recent quarter
When is the next earnings report?
Reporting date
June 30, 2024
Consensus EPS estimate
$-0.36
Fiscal period ending
2024-06-30
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.2%
2025-08-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-26 | $-0.07 | +30.0% | $16.06 | $17.23 | +7.3% |
| 2025-08-28 | $-0.04 | +90.0% | $16.12 | $13.83 | -14.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.07 | — | — | — | — |
| 2025-09-30 | $-0.10 | $-0.07 | +30.0% | — | — |
| 2025-06-30 | $-0.40 | $-0.04 | +90.0% | $7.02M | +458.6% |
| 2025-03-31 | $-0.14 | $0.00 | +100.0% | $7.02M | +458.6% |
| 2024-12-31 | $-0.41 | $-0.04 | +90.2% | $1.58M | -6.8% |
| 2024-09-30 | $-0.31 | $-0.28 | +9.7% | $1.58M | -6.8% |
| 2024-06-30 | $-0.36 | — | — | $1.26M | -41.2% |
| 2024-03-31 | $-0.11 | $0.00 | +100.0% | $1.26M | — |
| 2023-12-31 | $-0.40 | $0.00 | +100.0% | $1.69M | — |
| 2023-09-30 | $-0.12 | $-0.13 | -6.8% | $1.69M | — |
| 2023-06-30 | $-0.15 | $-0.14 | +6.7% | $2.14M | — |
Frequently asked questions
When does Mesoblast Ltd report next earnings?
Mesoblast Ltd (MESO) is scheduled to report earnings on June 30, 2024. The consensus EPS estimate is $-0.36.
Has Mesoblast Ltd beaten earnings estimates?
Mesoblast Ltd has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +77.6% over the last 4 quarters.
How does MESO stock react to earnings?
MESO stock has moved an average of -3.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.